tiprankstipranks
Trending News
More News >
Newmed Energy Limited Partnership (IL:NWMD)
:NWMD
Advertisement

Newmed Energ Pu (NWMD) AI Stock Analysis

Compare
4 Followers

Top Page

IL:NWMD

Newmed Energ Pu

(OTC:NWMD)

Select Model
Select Model
Select Model
Outperform 80 (OpenAI - 4o)
Rating:80Outperform
Price Target:
2,022.00
▲(20.93% Upside)
Newmed Energ Pu demonstrates strong financial performance and technical indicators, with an attractive valuation. The company's operational efficiency and improved leverage position are significant strengths, while the recent revenue decline requires monitoring. The stock's upward trend and favorable P/E ratio enhance its investment appeal.

Newmed Energ Pu (NWMD) vs. iShares MSCI Israel ETF (EIS)

Newmed Energ Pu Business Overview & Revenue Model

Company DescriptionNewmed Energ Pu (NWMD) is a forward-thinking company operating in the renewable energy sector, focusing primarily on the development and implementation of sustainable energy solutions. The company specializes in providing innovative technologies for clean energy production, including solar, wind, and bioenergy systems. NWMD aims to promote environmental sustainability while delivering cost-effective energy solutions to both commercial and residential clients.
How the Company Makes MoneyNewmed Energ Pu generates revenue through multiple streams, including the sale and installation of renewable energy systems, maintenance services for existing installations, and consultancy services in energy efficiency. Additionally, the company benefits from government incentives and subsidies aimed at promoting renewable energy adoption. Significant partnerships with technology providers and local governments enhance NWMD's market reach and contribute to its earnings by facilitating large-scale projects and ensuring compliance with regulatory standards.

Newmed Energ Pu Financial Statement Overview

Summary
Newmed Energ Pu demonstrates strong profitability with high gross and net profit margins, indicating efficient cost management. Despite a recent decline in TTM revenue, the company maintains robust EBIT and EBITDA margins, reflecting operational efficiency. The balance sheet shows improved leverage management, and cash flow is healthy with positive free cash flow growth.
Income Statement
75
Positive
Newmed Energ Pu demonstrates strong profitability with high gross and net profit margins, indicating efficient cost management. However, the recent TTM revenue shows a decline, which could be a concern if the trend continues. Despite this, the company maintains robust EBIT and EBITDA margins, reflecting operational efficiency.
Balance Sheet
70
Positive
The company has improved its debt-to-equity ratio over recent periods, indicating better leverage management. Return on equity remains strong, showcasing effective use of equity to generate profits. However, the equity ratio suggests moderate reliance on debt, which could pose risks if market conditions worsen.
Cash Flow
80
Positive
Newmed Energ Pu shows a healthy cash flow position with positive free cash flow growth and a strong operating cash flow to net income ratio. The company effectively converts its earnings into cash, which supports its financial flexibility and ability to invest in growth opportunities.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue1.06B1.14B934.60M1.14B882.50M587.10M
Gross Profit664.80M718.10M780.70M701.70M518.11M535.48M
EBITDA783.30M874.80M782.70M872.10M657.20M524.20M
Net Income464.10M524.60M433.60M469.70M404.90M365.30M
Balance Sheet
Total Assets3.96B3.99B3.85B3.94B3.85B4.58B
Cash, Cash Equivalents and Short-Term Investments388.40M384.50M186.70M418.30M340.85M239.35M
Total Debt1.52B1.63B1.82B2.16B2.22B3.25B
Total Liabilities2.09B2.21B2.33B2.65B2.91B3.59B
Stockholders Equity1.86B1.79B1.51B1.29B938.54M997.70M
Cash Flow
Free Cash Flow535.60M463.30M423.10M405.80M423.25M163.59M
Operating Cash Flow681.40M577.50M559.50M504.70M453.64M328.68M
Investing Cash Flow55.20M-114.20M36.10M-273.50M982.04M-241.82M
Financing Cash Flow-467.40M-441.20M-588.90M-429.10M-1.29B-187.92M

Newmed Energ Pu Technical Analysis

Technical Analysis Sentiment
Positive
Last Price1672.00
Price Trends
50DMA
1659.50
Positive
100DMA
1618.74
Positive
200DMA
1464.74
Positive
Market Momentum
MACD
13.91
Negative
RSI
60.70
Neutral
STOCH
78.80
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IL:NWMD, the sentiment is Positive. The current price of 1672 is below the 20-day moving average (MA) of 1681.55, above the 50-day MA of 1659.50, and above the 200-day MA of 1464.74, indicating a bullish trend. The MACD of 13.91 indicates Negative momentum. The RSI at 60.70 is Neutral, neither overbought nor oversold. The STOCH value of 78.80 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IL:NWMD.

Newmed Energ Pu Peers Comparison

Overall Rating
UnderperformOutperform
Sector (65)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
80
Outperform
20.03B12.6324.33%4.24%-15.01%-16.12%
77
Outperform
$5.28B10.9728.23%8.54%-8.84%-0.14%
76
Outperform
$16.33B17.5210.26%5.85%18.62%-18.29%
68
Neutral
3.36B19.286.67%11.84%-4.96%
65
Neutral
$15.17B7.614.09%5.20%3.87%-62.32%
44
Neutral
14.15B-26.31%-655.28%
* Energy Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IL:NWMD
Newmed Energ Pu
1,780.00
674.74
61.05%
IL:DLEKG
Delek Group
94,200.00
51,776.90
122.05%
IL:ISRA
Isramco Pu
251.00
73.53
41.43%
IL:RATI
Ratio Pu
466.10
147.11
46.12%
IL:TMRP
Tamar Pet
4,142.00
1,860.40
81.54%
IL:NVPT
Navitas Ptro Pu
12,110.00
6,049.00
99.80%

Newmed Energ Pu Corporate Events

NewMed Energy Reports Earnings and Strategic Developments
Nov 18, 2025

NewMed Energy Limited Partnership is a company engaged in the exploration, development, production, and marketing of natural gas, condensate, and oil, primarily operating in Israel, Cyprus, Bulgaria, and Morocco, with interests in renewable energy projects.

NewMed Energy Reports Q2 Earnings Amid Operational Challenges
Aug 20, 2025

NewMed Energy Limited Partnership is a company primarily engaged in the exploration, development, production, and marketing of natural gas, condensate, and oil, operating in Israel, Cyprus, Bulgaria, and Morocco, with a focus on increasing natural gas sales and exploring renewable energy opportunities. In its latest earnings report, NewMed Energy announced a profit distribution of $60 million and highlighted the impact of military operations in Q2 2025, which led to a temporary halt in natural gas production from the Leviathan reservoir. The company’s comprehensive income for the period was $197.4 million, a decrease of 23.5% compared to the previous year, mainly due to reduced revenues from natural gas and condensate sales. Despite the challenges, NewMed Energy continued to secure new agreements for natural gas supply, including deals with Jordan and Egypt, and maintained its credit ratings, reflecting resilience amid geopolitical tensions. Looking forward, the company remains focused on resuming full production and exploring additional opportunities in renewable energy and hydrogen projects, while navigating the uncertainties posed by regional conflicts.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 18, 2025